Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00613431 · ClinicalTrials.gov registry record · Phase 1

Effects of CS-8080 in Healthy Volunteers

A Phase 1 study of Healthy, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 1
Development phase
72
Enrollment target
1
Study location

NCT00613431 is a Phase 1 study of Healthy that has completed, run by Daiichi Sankyo. The registered enrollment target is 72 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00613431, a Phase 1 study of Healthy, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 1
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The main purposes of this study are to assess the safety and measure the pharmacokinetics of CS-8080 in healthy volunteers.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG CS8080

Study Locations (1)

New Jersey

  • MDS Pharma Services - Neptune City

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2008-01
Phase Phase 1

Sponsor

Daiichi Sankyo

236 total trials

What the Registry Record Tells You About NCT00613431

The ClinicalTrials.gov registry entry for NCT00613431 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00613431 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00613431 about?

NCT00613431 is a clinical study titled "Effects of CS-8080 in Healthy Volunteers". The main purposes of this study are to assess the safety and measure the pharmacokinetics of CS-8080 in healthy volunteers.

What is the current status of trial NCT00613431?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2008-01.

What conditions does trial NCT00613431 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00613431?

The interventions under investigation include: Placebo (DRUG), CS8080 (DRUG).

Who is sponsoring clinical trial NCT00613431?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00613431 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.